Events
Videos
Spotlight
My bookmarks
  3. Multidisciplinary Approach in the NAFLD/NASH Patient Care Pathway
5 minExpert Talk

Multidisciplinary Approach in the NAFLD/NASH Patient Care Pathway

About this session

There is a significant push within the medical community to devise simpler, more cost-efficient ways to assess and monitor NAFLD/NASH patients. In this 5-minute video, Dr. Manuel Romero-Gómez, professor of medicine at the University of Seville, Sevilla, Spain, discusses the need for a multidisciplinary approach in the NAFLD/NASH patient care pathway and how noninvasive tests like the Enhanced Liver Fibrosis (ELF™) Test can help.

Clinical ChemistryChronic Disease Management
Request information

The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.

In the U.S., the ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.

You are entering a global domain of Siemens Healthineers.

If you choose to continue, please note that information in this domain is meant to be generic and country-independent. The devices displayed or mentioned may not be commercially available in all countries and their future availability cannot be guaranteed.

Continue

All EventsVideosShape 25 SpotlightCorporate websiteHealthcare professionalsFAQSubscribe to our newsletterJobs & Careers